OUR PRODUCTS

MOBILE APPS

GENERAL INFO

XGN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Exagen (XGN) Earnings Date & Reports

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

XGN is expected to report earnings to fall 22.43% to -16 cents per share on November 18

Q3'25

Est.

$-0.16

Q2'25

Missed

by $0.06

Q1'25

Beat

by $0.02

Q4'24

Beat

by $0.12

Q3'24

Beat

by $0.01

The last earnings report on July 29 showed earnings per share of -20 cents, missing the estimate of -15 cents. With 248.62K shares outstanding, the current market capitalization sits at 214.32M.

View a ticker or compare two or three

Compare

XGN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For XGN
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. XGN showed earnings on July 29, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases

Industry MedicalSpecialties

Profile

Fundamentals

Details

Industry

N/A

Address

1261 Liberty Way

Phone

+1 760 560-1501

Employees

179

Web

https://www.exagen.com